Which topic involves evaluating the safety and tolerability of a therapy in a clinical trial?

Which topic involves evaluating the safety and tolerability of a therapy in a clinical trial?

• A. Evaluation of Safety and Tolerability
• B. Choice of Variables and Data Collection
• C. Integrated Summary
• D. Reporting

Answer: (A)

Evaluating the safety and tolerability of a therapy in a clinical trial focuses on monitoring how well participants tolerate the treatment and whether any adverse effects are acceptable. This involves collecting and grading adverse events, tracking relevant safety lab results and vital signs, and identifying dose-limiting toxicities to determine if the risk remains favorable compared with potential benefit. These safety endpoints guide decisions on dose adjustments, continuation, or termination, and underpin the overall risk–benefit assessment for moving the therapy forward. The other topics address how data are chosen and collected, how results are synthesized across studies, or how findings are communicated, rather than the ongoing assessment of safety and tolerability.

Evaluating the safety and tolerability of a therapy in a clinical trial focuses on monitoring how well participants tolerate the treatment and whether any adverse effects are acceptable. This involves collecting and grading adverse events, tracking relevant safety lab results and vital signs, and identifying dose-limiting toxicities to determine if the risk remains favorable compared with potential benefit. These safety endpoints guide decisions on dose adjustments, continuation, or termination, and underpin the overall risk–benefit assessment for moving the therapy forward. The other topics address how data are chosen and collected, how results are synthesized across studies, or how findings are communicated, rather than the ongoing assessment of safety and tolerability.